The BSE Sensex and NSE Nifty are likely to open on a soft-to-cautious note on Thursday tracking SGX Nifty
The BSE Sensex and NSE Nifty are likely to open on a soft-to-cautious note on Thursday tracking SGX Nifty, mixed Asian markets amid rising uncertainty over the fate of GST.
At 8.26 am (IST), SGX Nifty was up 10 points, or 0.13 per cent, at 7,656.50.
- REC share price, PFC stock fall even as power stocks rally on liquidity push from Modi’s package
- IRCTC shares up 5% as train reservation booking set to open; stock price more than doubles in less than a year
- Sun Pharma, Aurobindo Pharma among top stock picks from Pharma sector; CLSA sees gain up to 30%
Asian stocks slipped on Thursday as weak oil prices continued to feed global growth worries, while the euro held solid gains after a policymaker poured cold water on market expectations of more easing by the European Central Bank.
The S&P 500 tracked weaker commodities and lost 0.8 per cent on Wednesday, while the Dow lost 0.4 per cent and the Nasdaq shed 1.5 per cent.
Back home, stock markets tumbled for a sixth straight session on Wednesday as the BSE Sensex plummeted by 274 points while the NSE Nifty cracked below the 7,700-level.
Shares of Biocon and Aurobindo Pharma will remain in focus on Friday. NeoBiocon, a collaboration between Biocon Ltd and BR Shetty led UAE-based Neopharma, has partnered with Novartis Middle East FZE to market diabetes drugs Jalra and Jalra-M in the UAE.
Drug firm Aurobindo Pharma has received final approval from the US health regulator to manufacture and market its oral contraceptive Levonorgestrel tablets.
(With agency inputs)